PFO
HZNP

Pathstone Family Office’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pathstone Family Office’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$272K Buy
+2,355
New +$272K ﹤0.01% 1354
2017
Q2 		– Sell
-28
Closed – – 699
2017
Q1 		$0 Buy
+28
New – ﹤0.01% 648